Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDNA | Common Stock | Options Exercise | $610 | +500 | +0.82% | $1.22* | 61.8K | Mar 9, 2022 | Direct | F1 |
transaction | CDNA | Common Stock | Sale | -$16.7K | -500 | -0.81% | $33.41 | 61.3K | Mar 9, 2022 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDNA | Stock Option (right to buy) | Options Exercise | $0 | -500 | -4% | $0.00 | 12K | Mar 9, 2022 | Common Stock | 500 | $1.22 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.30 to $33.55, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
F3 | 1/12th of the shares subject to the option vested on August 13, 2017 and the shares subject to the option vested monthly thereafter through July 13, 2018. |